Passage Bio
PASG
70 hedge funds and large institutions have $403M invested in Passage Bio in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 12 closing their positions.
33% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 12
6% more funds holding
Funds holding: 66 → 70 (+4)
0.1% less ownership
Funds ownership: 3.48% → 3.38% (-0.1%)
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
53% less capital invested
Capital invested by funds: $863M → $403M (-$459M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.83M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.77M |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$1.72M |
| 4 |
Millennium Management
New York
|
+$982K |
| 5 |
State Street
Boston,
Massachusetts
|
+$538K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alkeon Capital Management
New York
|
-$13.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.92M |
| 3 |
AG
Artal Group
Luxembourg
|
-$3.76M |
| 4 |
AI
Atom Investors
Austin,
Texas
|
-$2.13M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$1.37M |
PASG Hedge Fund Activity: Q3 2020 in Review
70 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q3 2020, worth a combined $403M — down 53% from $863M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new PASG positions and 12 closed out — a net gain of 4 holders — while 16 added to existing stakes and 20 trimmed.
The largest buyer was BlackRock, adding an estimated $1.83M. The largest seller was Alkeon Capital Management, exiting entirely with an estimated $13.8M sold.
- 70 institutional investors held Passage Bio (PASG) as of Q3 2020, up from 66 in Q2 2020.
- Funds reported $403M of Passage Bio stock for Q3 2020, down 53% quarter-over-quarter.
- 16 funds opened new Passage Bio positions in Q3 2020 and 12 closed out, a net change of +4 holders.
- The largest Passage Bio buyer in Q3 2020 was BlackRock, an estimated $1.83M added.
- The largest Passage Bio seller in Q3 2020 was Alkeon Capital Management, an estimated $13.8M sold.
Based on aggregated 13F filings for Q3 2020.